Health and Healthcare

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

141 Articles

Jon C. Ogg | Mar 25, 2013 at 10:50 AM EDT

The Risk-Reward Case for Sarepta — Stock Going to $19 or $47 by Mid-May

ThinkstockSarepta Therapeutics Inc. (NASDAQ: SRPT) should have received a huge boost from “The Barron’s Effect” on Monday. The financial publication,…

Paul Ausick | Oct 3, 2012 at 4:02 PM EDT

24/7 Wall St. Closing Bell — October 3, 2012: Markets Just Bump Along (MOS, CSCO, MHP, KORS, WPRT, FDO, MON, RPM, MAR, ISCA, HPQ, SRPT, VRNG, GOOG, LEAP, PCS)

The three major U.S. stock indexes opened slightly higher this morning following a refusal by Spain’s prime minister to seek…

Jon C. Ogg | Oct 3, 2012 at 12:53 PM EDT

How Sarepta Got On The Map

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a company which many biohealth and biotech investors have likely never heard of. At least…

247sam | Oct 3, 2012 at 11:11 AM EDT

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market is up slightly Wednesday, with the Dow Jones Industrial Average up 0.07%, the…

Paul Ausick | Jul 24, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and…

247sam | Jul 24, 2012 at 11:13 AM EDT

Today’s Market Winners and Losers

Once again, concerns over European debt is sending stocks tumbling. The Dow is down 0.61%, the Nasdaq is down 0.39% and the…

1 … 8 9 10

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

The Risk-Reward Case for Sarepta — Stock Going to $19 or $47 by Mid-May

24/7 Wall St. Closing Bell — October 3, 2012: Markets Just Bump Along (MOS, CSCO, MHP, KORS, WPRT, FDO, MON, RPM, MAR, ISCA, HPQ, SRPT, VRNG, GOOG, LEAP, PCS)

How Sarepta Got On The Map

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

Today’s Market Winners and Losers

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

Analyst: Forget the Chip Cycle, Because AI Demand Has Permanently Rewired Semiconductor Pricing

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

The Risk-Reward Case for Sarepta — Stock Going to $19 or $47 by Mid-May

24/7 Wall St. Closing Bell — October 3, 2012: Markets Just Bump Along (MOS, CSCO, MHP, KORS, WPRT, FDO, MON, RPM, MAR, ISCA, HPQ, SRPT, VRNG, GOOG, LEAP, PCS)

How Sarepta Got On The Map

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — July 24, 2012: Markets Fall on Weak Quarterly Results

Today’s Market Winners and Losers

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

Analyst: Forget the Chip Cycle, Because AI Demand Has Permanently Rewired Semiconductor Pricing

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It